These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 22033153)

  • 1. Modulation of AT-1R/CHOP-JNK-Caspase12 pathway by olmesartan treatment attenuates ER stress-induced renal apoptosis in streptozotocin-induced diabetic mice.
    Lakshmanan AP; Thandavarayan RA; Palaniyandi SS; Sari FR; Meilei H; Giridharan VV; Soetikno V; Suzuki K; Kodama M; Watanabe K
    Eur J Pharm Sci; 2011 Dec; 44(5):627-34. PubMed ID: 22033153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of AT-1R/MAPK cascade by an olmesartan treatment attenuates diabetic nephropathy in streptozotocin-induced diabetic mice.
    Lakshmanan AP; Thandavarayan RA; Watanabe K; Sari FR; Meilei H; Giridharan VV; Sukumaran V; Soetikno V; Arumugam S; Suzuki K; Kodama M
    Mol Cell Endocrinol; 2012 Jan; 348(1):104-11. PubMed ID: 21827824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An angiotensin II type-I receptor blocker, olmesartan medoxomil, attenuates lipid peroxidation in renal injury induced by subtotal nephrectomy.
    Takahashi T; Konta T; Takasaki S; Ichikawa K; Takeishi Y; Kubota I
    Clin Exp Nephrol; 2007 Sep; 11(3):202-208. PubMed ID: 17891346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olmesartan attenuates the development of heart failure after experimental autoimmune myocarditis in rats through the modulation of ANG 1-7 mas receptor.
    Sukumaran V; Veeraveedu PT; Gurusamy N; Lakshmanan AP; Yamaguchi K; Ma M; Suzuki K; Nagata M; Takagi R; Kodama M; Watanabe K
    Mol Cell Endocrinol; 2012 Apr; 351(2):208-19. PubMed ID: 22200414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1-7) mas receptor expression associated with its PPAR-γ agonist action.
    Lakshmanan AP; Watanabe K; Thandavarayan RA; Sari FR; Harima M; Giridharan VV; Soetikno V; Kodama M; Aizawa Y
    Free Radic Res; 2011 May; 45(5):575-84. PubMed ID: 21381899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Olmesartan, an AT1 antagonist, attenuates oxidative stress, endoplasmic reticulum stress and cardiac inflammatory mediators in rats with heart failure induced by experimental autoimmune myocarditis.
    Sukumaran V; Watanabe K; Veeraveedu PT; Gurusamy N; Ma M; Thandavarayan RA; Lakshmanan AP; Yamaguchi K; Suzuki K; Kodama M
    Int J Biol Sci; 2011 Feb; 7(2):154-67. PubMed ID: 21383952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olmesartan attenuates type 2 diabetes-associated liver injury: Cross-talk of AGE/RAGE/JNK, STAT3/SCOS3 and RAS signaling pathways.
    Abo El-Nasr NME; Saleh DO; Mahmoud SS; Nofal SM; Abdelsalam RM; Safar MM; El-Abhar HS
    Eur J Pharmacol; 2020 May; 874():173010. PubMed ID: 32067934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dynamic changes of endoplasmic reticulum stress pathway markers GRP78 and CHOP in the hippocampus of diabetic mice.
    Zhao Y; Yan Y; Zhao Z; Li S; Yin J
    Brain Res Bull; 2015 Feb; 111():27-35. PubMed ID: 25529350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valsartan protects against ER stress-induced myocardial apoptosis via CHOP/Puma signaling pathway in streptozotocin-induced diabetic rats.
    Wu T; Dong Z; Geng J; Sun Y; Liu G; Kang W; Zhang Y; Ge Z
    Eur J Pharm Sci; 2011 Apr; 42(5):496-502. PubMed ID: 21345370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of PERK-ATF4-CHOP pathway by Astragaloside IV is associated with the inhibition of endoplasmic reticulum stress-induced podocyte apoptosis in diabetic rats.
    Chen Y; Gui D; Chen J; He D; Luo Y; Wang N
    Cell Physiol Biochem; 2014; 33(6):1975-87. PubMed ID: 25012492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal protection by low dose irbesartan in diabetic nephropathy is paralleled by a reduction of inflammation, not of endoplasmic reticulum stress.
    Hartner A; Cordasic N; Klanke B; Menendez-Castro C; Veelken R; Schmieder RE; Hilgers KF
    Biochim Biophys Acta; 2014 Apr; 1842(4):558-65. PubMed ID: 24418215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrarenal renin-angiotensin system mediates fatty acid-induced ER stress in the kidney.
    Li C; Lin Y; Luo R; Chen S; Wang F; Zheng P; Levi M; Yang T; Wang W
    Am J Physiol Renal Physiol; 2016 Mar; 310(5):F351-63. PubMed ID: 26672616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoplasmic reticulum stress-induced neuronal inflammatory response and apoptosis likely plays a key role in the development of diabetic encephalopathy.
    Wang Z; Huang Y; Cheng Y; Tan Y; Wu F; Wu J; Shi H; Zhang H; Yu X; Gao H; Lin L; Cai J; Zhang J; Li X; Cai L; Xiao J
    Oncotarget; 2016 Nov; 7(48):78455-78472. PubMed ID: 27793043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olmesartan protects against oxidative stress possibly through the Nrf2 signaling pathway and inhibits inflammation in daunorubicin-induced nephrotoxicity in rats.
    Gounder VK; Arumugam S; Arozal W; Thandavarayan RA; Pitchaimani V; Harima M; Suzuki K; Nomoto M; Watanabe K
    Int Immunopharmacol; 2014 Feb; 18(2):282-9. PubMed ID: 24291173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olmesartan ameliorates progressive glomerular injury in subtotal nephrectomized rats through suppression of superoxide production.
    Fujimoto S; Satoh M; Horike H; Hatta H; Haruna Y; Kobayashi S; Namikoshi T; Arakawa S; Tomita N; Kashihara N
    Hypertens Res; 2008 Feb; 31(2):305-13. PubMed ID: 18360051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of angiotensin II receptor antagonist olmesartan on renal hemodynamic variables and vascular structural properties in streptozotocin-induced diabetic rats.
    Song HF; Chen JF; Sun NL; Li HW
    Chin Med J (Engl); 2011 Feb; 124(4):562-7. PubMed ID: 21362282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of combination of calcium antagonist, azelnidipine, and AT1 receptor blocker, olmesartan, on atherosclerosis in apolipoprotein E-deficient mice.
    Suzuki J; Iwai M; Li Z; Li JM; Min LJ; Ide A; Yoshii T; Oshita A; Mogi M; Horiuchi M
    J Hypertens; 2005 Jul; 23(7):1383-9. PubMed ID: 15942461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of endoplasmic reticulum chaperone GRP78 by high glucose in hippocampus of streptozotocin-induced diabetic mice and C6 astrocytic cells.
    Wong DP; Chu JM; Hung VK; Lee DK; Cheng CH; Yung KK; Yue KK
    Neurochem Int; 2013 Nov; 63(6):551-60. PubMed ID: 24056253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of irbesartan on the antioxidant defence system and nitric oxide release in diabetic rat kidney.
    Anjaneyulu M; Chopra K
    Am J Nephrol; 2004; 24(5):488-96. PubMed ID: 15353911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grape seed proanthocyanidins protect against streptozotocin‑induced diabetic nephropathy by attenuating endoplasmic reticulum stress‑induced apoptosis.
    Gao Z; Liu G; Hu Z; Shi W; Chen B; Zou P; Li X
    Mol Med Rep; 2018 Aug; 18(2):1447-1454. PubMed ID: 29901130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.